{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T23:35:37Z","timestamp":1788910537654,"version":"build-2803163510"},"reference-count":103,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T00:00:00Z","timestamp":1727049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"NIH\/NCI","award":["1R21CA277418"],"award-info":[{"award-number":["1R21CA277418"]}]},{"name":"NIH\/NCI","award":["1R01CA286527"],"award-info":[{"award-number":["1R01CA286527"]}]},{"name":"NIH\/NCI","award":["24B14"],"award-info":[{"award-number":["24B14"]}]},{"name":"Florida Department of Health","award":["1R21CA277418"],"award-info":[{"award-number":["1R21CA277418"]}]},{"name":"Florida Department of Health","award":["1R01CA286527"],"award-info":[{"award-number":["1R01CA286527"]}]},{"name":"Florida Department of Health","award":["24B14"],"award-info":[{"award-number":["24B14"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Oncology"],"abstract":"<jats:p>Docetaxel is a commonly used taxane chemotherapeutic agent in the treatment of a variety of cancers, including breast cancer, ovarian cancer, prostate cancer, non-small cell lung cancer, gastric cancer, and head and neck cancer. Docetaxel exerts its anti-cancer effects through inhibition of the cell cycle and induction of proapoptotic activity. However, docetaxel also impacts rapidly proliferating normal cells in the scalp hair follicles (HFs), rendering the HFs vulnerable to docetaxel-induced cell death and leading to chemotherapy-induced alopecia (CIA). In severe cases, docetaxel causes persistent or permanent CIA (pCIA) when hair does not grow back completely six months after chemotherapy cessation. Hair loss has severe negative impacts on patients\u2019 quality of life and may even compromise their compliance with treatment. This review discusses the notable prevalence of docetaxel-induced CIA and pCIA, as well as their prevention and management. At this moment, scalp cooling is the standard of care to prevent CIA. Treatment options to promote hair regrowth include but are not limited to minoxidil, photobiomodulation (PBMT), and platelet-rich plasma (PRP). In addition, a handful of current clinical trials are exploring additional agents to treat or prevent CIA. Research models of CIA, particularly ex vivo human scalp HF organ culture and in vivo mouse models with human scalp xenografts, will help expedite the translation of bench findings of CIA prevention and\/or amelioration to the clinic.<\/jats:p>","DOI":"10.3390\/curroncol31090423","type":"journal-article","created":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T09:16:10Z","timestamp":1727428570000},"page":"5709-5721","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Chemotherapy-Induced Alopecia by Docetaxel: Prevalence, Treatment and Prevention"],"prefix":"10.3390","volume":"31","author":[{"given":"Aleymi M.","family":"Perez","sequence":"first","affiliation":[{"name":"Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, Miller School of Medicine, University of Miami, Miami, FL 33136, USA"},{"name":"Lake Erie College of Osteopathic Medicine, Bradenton, FL 34211, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6997-4157","authenticated-orcid":false,"given":"Nicole I.","family":"Haberland","sequence":"additional","affiliation":[{"name":"Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, Miller School of Medicine, University of Miami, Miami, FL 33136, USA"},{"name":"College of Medicine, University of Central Florida, Orlando, FL 32827, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariya","family":"Miteva","sequence":"additional","affiliation":[{"name":"Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, Miller School of Medicine, University of Miami, Miami, FL 33136, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6307-7986","authenticated-orcid":false,"given":"Tongyu C.","family":"Wikramanayake","sequence":"additional","affiliation":[{"name":"Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, Miller School of Medicine, University of Miami, Miami, FL 33136, USA"},{"name":"Cancer Control Program, Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, FL 33136, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,9,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1200\/JCO.1995.13.10.2643","article-title":"Docetaxel","volume":"13","author":"Cortes","year":"1995","journal-title":"J. Clin. Oncol."},{"key":"ref_2","unstructured":"Ismail, U., and Killeen, R.B. (2024). Taxane Toxicity, StatPearls."},{"key":"ref_3","unstructured":"Farha, N.G., and Kasi, A. (2024). Docetaxel, StatPearls."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0305-7372(03)00097-5","article-title":"Mode of action of docetaxel\u2014A basis for combination with novel anticancer agents","volume":"29","author":"Herbst","year":"2003","journal-title":"Cancer Treat. Rev."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1007\/s11136-019-02117-9","article-title":"Estimating utilities\/disutilities for high-risk metastatic hormone-sensitive prostate cancer (mHSPC) and treatment-related adverse events","volume":"28","author":"Hall","year":"2019","journal-title":"Qual. Life Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1001\/jamaoncol.2021.7298","article-title":"Efficacy and Safety of Autologous Dendritic Cell-Based Immunotherapy, Docetaxel, and Prednisone vs Placebo in Patients with Metastatic Castration-Resistant Prostate Cancer: The VIABLE Phase 3 Randomized Clinical Trial","volume":"8","author":"Vogelzang","year":"2022","journal-title":"JAMA Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1177\/1120672120969045","article-title":"Ophthalmic adverse effects of taxanes: The Mayo Clinic experience","volume":"32","author":"Fortes","year":"2022","journal-title":"Eur. J. Ophthalmol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.jaad.2018.03.055","article-title":"Hair disorders in patients with cancer","volume":"80","author":"Shapiro","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1056\/NEJM199908123410706","article-title":"The biology of hair follicles","volume":"341","author":"Paus","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.jaad.2017.01.060","article-title":"Commonly prescribed medications associated with alopecia","volume":"88","author":"Mounessa","year":"2023","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ad.2021.09.003","article-title":"Chemotherapy, Alopecia, and Scalp Cooling Systems","volume":"113","author":"Amarillo","year":"2022","journal-title":"Actas Dermosifiliogr."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Kinoshita, T., Nakayama, T., Fukuma, E., Inokuchi, M., Ishiguro, H., Ogo, E., Kikuchi, M., Jinno, H., Yamazaki, N., and Toi, M. (2019). Efficacy of Scalp Cooling in Preventing and Recovering From Chemotherapy-Induced Alopecia in Breast Cancer Patients: The HOPE Study. Front. Oncol., 9.","DOI":"10.3389\/fonc.2019.00733"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e390428","DOI":"10.1200\/EDBK_390428","article-title":"Improving Quality of Life During Chemotherapy: Cannabinoids, Cryotherapy, and Scalp Cooling","volume":"43","author":"Michel","year":"2023","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.3390\/curroncol30040275","article-title":"Prevention and Treatment of Chemotherapy-Induced Alopecia: What Is Available and What Is Coming?","volume":"30","author":"Wikramanayake","year":"2023","journal-title":"Curr. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3955","DOI":"10.1007\/s00520-021-06748-y","article-title":"\u201cDear hair loss\u201d-illness perceptions of female patients with chemotherapy-induced alopecia","volume":"30","author":"Versluis","year":"2022","journal-title":"Support. Care Cancer"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s10549-018-4855-2","article-title":"Persistent major alopecia following adjuvant docetaxel for breast cancer: Incidence, characteristics, and prevention with scalp cooling","volume":"171","author":"Martin","year":"2018","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e13395","DOI":"10.1111\/ecc.13395","article-title":"Permanent hair loss associated with taxane chemotherapy use in breast cancer: A retrospective survey at two tertiary UK cancer centres","volume":"30","author":"Chan","year":"2021","journal-title":"Eur. J. Cancer Care"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.jaad.2010.03.020","article-title":"Permanent chemotherapy-induced alopecia: A review","volume":"64","author":"Palamaras","year":"2011","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jdcr.2022.01.035","article-title":"Permanent chemotherapy-induced alopecia after hematopoietic stem cell transplantation treated with low-dose oral minoxidil","volume":"22","author":"Lyakhovitsky","year":"2022","journal-title":"JAAD Case Rep."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e151","DOI":"10.1016\/j.jaad.2010.06.064","article-title":"Docetaxel and permanent alopecia","volume":"68","author":"Tosti","year":"2013","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1634\/theoncologist.2018-0184","article-title":"Permanent Chemotherapy-Induced Alopecia in Patients with Breast Cancer: A 3-Year Prospective Cohort Study","volume":"24","author":"Kang","year":"2019","journal-title":"Oncologist"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1200\/JCO.22.02546","article-title":"Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients with Non-Small-Cell Lung Cancer Previously Treated with Chemotherapy","volume":"41","author":"Hanna","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"114007","DOI":"10.1016\/j.ejca.2024.114007","article-title":"A global phase II randomized trial comparing oral taxane ModraDoc006\/r to intravenous docetaxel in metastatic castration resistant prostate cancer","volume":"202","author":"Vaishampayan","year":"2024","journal-title":"Eur. J. Cancer"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1200\/JCO.20.03398","article-title":"Adjuvant Trastuzumab Emtansine Versus Paclitaxel in Combination with Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT): A Randomized Clinical Trial","volume":"39","author":"Tolaney","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.2169\/internalmedicine.5089-20","article-title":"A Multicenter Study of Docetaxel at a Dose of 100 mg\/m(2) in Japanese Patients with Advanced or Recurrent Breast Cancer","volume":"60","author":"Hirata","year":"2021","journal-title":"Intern. Med."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Yoon, S.E., Kim, Y., Cho, J., Kang, M., Sung, H.H., Jeon, H.G., Jeong, B.C., Seo, S.I., Jeon, S.S., and Lee, H.M. (2019). A retrospective feasibility study of biweekly docetaxel in patients with high-risk metastatic castration-naive prostate cancer. BMC Urol., 19.","DOI":"10.1186\/s12894-019-0463-7"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Yang, H., Xu, L., Guan, S., Hao, X., Ge, Z., Tong, F., Cao, Y., Liu, P., Zhou, B., and Cheng, L. (2022). Neoadjuvant docetaxel and capecitabine (TX) versus docetaxel and epirubicin (TE) for locally advanced or early her2-negative breast cancer: An open-label, randomized, multi-center, phase II Trial. BMC Cancer, 22.","DOI":"10.1186\/s12885-022-10439-0"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Yu, D., Wang, Z., He, T., and Yang, L. (2022). Neoadjuvant Bevacizumab Plus Docetaxel\/Cisplatin\/Capecitabine Chemotherapy in Locally Advanced Gastric Cancer Patients: A Pilot Study. Front. Surg., 9.","DOI":"10.3389\/fsurg.2022.842828"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s10549-021-06145-3","article-title":"Subcutaneous trastuzumab with pertuzumab and docetaxel in HER2-positive metastatic breast cancer: Final analysis of MetaPHER, a phase IIIb single-arm safety study","volume":"187","author":"Kuemmel","year":"2021","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Li, R., Tian, F., Qi, Y., Ma, L., Zhou, T., Li, Y., Hui, T., Zhang, L., Wang, S., and Song, Z. (2019). Pegylated liposomal doxorubicin plus cyclophosphamide followed by docetaxel as neoadjuvant chemotherapy in locally advanced breast cancer (registration number: ChiCTR1900023052). Sci. Rep., 9.","DOI":"10.1038\/s41598-019-54387-5"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.12669\/pjms.39.5.7446","article-title":"Effect of different chemotherapy schemes on early-stage breast cancer patients with Low HER-2 expression","volume":"39","author":"Xu","year":"2023","journal-title":"Pak. J. Med. Sci."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.lungcan.2019.08.011","article-title":"An open-label phase IB study to evaluate GSK3052230 in combination with paclitaxel and carboplatin, or docetaxel, in FGFR1-amplified non-small cell lung cancer","volume":"136","author":"Morgensztern","year":"2019","journal-title":"Lung Cancer"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1200\/JCO.20.00184","article-title":"Randomized Controlled Trial of Trastuzumab with or without Chemotherapy for HER2-Positive Early Breast Cancer in Older Patients","volume":"38","author":"Sawaki","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1001\/jamadermatol.2018.5071","article-title":"Assessment of Quality of Life and Treatment Outcomes of Patients With Persistent Postchemotherapy Alopecia","volume":"155","author":"Chan","year":"2019","journal-title":"JAMA Dermatol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e11031","DOI":"10.15252\/emmm.201911031","article-title":"CDK4\/6 inhibition mitigates stem cell damage in a novel model for taxane-induced alopecia","volume":"11","author":"Purba","year":"2019","journal-title":"EMBO Mol. Med."},{"key":"ref_36","unstructured":"Feingold, K.R., Anawalt, B., Blackman, M.R., Boyce, A., Chrousos, G., Corpas, E., de Herder, W.W., Dhatariya, K., Dungan, K., and Hofland, J. (2000). Male Androgenetic Alopecia, Endotext."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jdcr.2021.12.025","article-title":"Permanent chemotherapy-induced alopecia presenting with erosive pustular dermatosis-like retention hyperkeratosis","volume":"21","author":"Kolla","year":"2022","journal-title":"JAAD Case Rep."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1093\/annonc\/mds095","article-title":"Permanent scalp alopecia related to breast cancer chemotherapy by sequential fluorouracil\/epirubicin\/cyclophosphamide (FEC) and docetaxel: A prospective study of 20 patients","volume":"23","author":"Kluger","year":"2012","journal-title":"Ann. Oncol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1001\/jamadermatol.2020.1867","article-title":"Association between ABCB1 Genetic Variants and Persistent Chemotherapy-Induced Alopecia in Women with Breast Cancer","volume":"156","author":"Martin","year":"2020","journal-title":"JAMA Dermatol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jaad.2020.06.1009","article-title":"Oral minoxidil treatment for hair loss: A review of efficacy and safety","volume":"84","author":"Randolph","year":"2021","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e2020074","DOI":"10.5826\/dpc.1003a74","article-title":"Prevention and Treatment of Chemotherapy-Induced Alopecia","volume":"10","author":"Rossi","year":"2020","journal-title":"Dermatol. Pract. Concept."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/oxfordjournals.annonc.a058986","article-title":"Minoxidil (Mx) as a prophylaxis of doxorubicin--induced alopecia","volume":"5","author":"Rodriguez","year":"1994","journal-title":"Ann. Oncol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s40257-018-0409-y","article-title":"Off-Label Use of Topical Minoxidil in Alopecia: A Review","volume":"20","author":"Stoehr","year":"2019","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"e14938","DOI":"10.1097\/MD.0000000000014938","article-title":"The role of photobiomodulation when associated with microneedling in female pattern hair loss: A randomized, double blind, parallel group, three arm, clinical study protocol","volume":"98","author":"Moita","year":"2019","journal-title":"Medicine"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Dompe, C., Moncrieff, L., Matys, J., Grzech-Lesniak, K., Kocherova, I., Bryja, A., Bruska, M., Dominiak, M., Mozdziak, P., and Skiba, T.H.I. (2020). Photobiomodulation-Underlying Mechanism and Clinical Applications. J. Clin. Med., 9.","DOI":"10.3390\/jcm9061724"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2147\/CCID.S184979","article-title":"Photobiomodulation for the management of alopecia: Mechanisms of action, patient selection and perspectives","volume":"12","author":"Hamblin","year":"2019","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s40257-013-0060-6","article-title":"Efficacy and safety of a low-level laser device in the treatment of male and female pattern hair loss: A multicenter, randomized, sham device-controlled, double-blind study","volume":"15","author":"Jimenez","year":"2014","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1097\/DSS.0000000000003472","article-title":"Photobiomodulation Therapy With Different Wavebands for Hair Loss: A Systematic Review and Meta-Analysis","volume":"48","author":"Zhang","year":"2022","journal-title":"Dermatol. Surg."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/lsm.22170","article-title":"Low-level laser (light) therapy (LLLT) for treatment of hair loss","volume":"46","author":"Avci","year":"2014","journal-title":"Lasers Surg. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s10103-012-1139-7","article-title":"Low-level laser treatment accelerated hair regrowth in a rat model of chemotherapy-induced alopecia (CIA)","volume":"28","author":"Wikramanayake","year":"2013","journal-title":"Lasers Med. Sci."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Robijns, J., Nair, R.G., Lodewijckx, J., Arany, P., Barasch, A., Bjordal, J.M., Bossi, P., Chilles, A., Corby, P.M., and Epstein, J.B. (2022). Photobiomodulation therapy in management of cancer therapy-induced side effects: WALT position paper 2022. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.927685"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2142035","DOI":"10.1080\/09546634.2022.2142035","article-title":"A comprehensive review of platelet-rich plasma for the treatment of dermatologic disorders","volume":"34","author":"Pixley","year":"2023","journal-title":"J. Dermatolog. Treat."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.fsc.2020.01.009","article-title":"Platelet-Rich Plasma for Hair Restoration","volume":"28","author":"Justicz","year":"2020","journal-title":"Facial Plast. Surg. Clin. N. Am."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e03660","DOI":"10.1016\/j.heliyon.2020.e03660","article-title":"What is the potential use of platelet-rich-plasma (PRP) in cancer treatment? A mini review","volume":"6","author":"Luzo","year":"2020","journal-title":"Heliyon"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Eichler, C., Baucks, C., Uner, J., Pahmeyer, C., Ratiu, D., Gruettner, B., Malter, W., and Warm, M. (2020). Platelet-Rich Plasma (PRP) in Breast Cancer Patients: An Application Analysis of 163 Sentinel Lymph Node Biopsies. Biomed. Res. Int., 2020.","DOI":"10.1155\/2020\/3432987"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000503836","article-title":"The Role of Platelet-Rich Plasma in the Prevention of Chemotherapy-Induced Alopecia","volume":"6","author":"Stamatiou","year":"2020","journal-title":"Skin. Appendage Disord."},{"key":"ref_57","first-page":"24","article-title":"Platelet-rich plasma for the treatment of alopecia: A systematic review and meta-analysis","volume":"21","author":"Cruciani","year":"2023","journal-title":"Blood Transfus."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ijwd.2018.05.001","article-title":"Female pattern hair loss: A clinical, pathophysiologic, and therapeutic review","volume":"4","author":"Fabbrocini","year":"2018","journal-title":"Int. J. Womens Dermatol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1080\/13543784.2017.1303480","article-title":"Bimatoprost for the treatment of eyelash, eyebrow and scalp alopecia","volume":"26","author":"Tosti","year":"2017","journal-title":"Expert. Opin. Investig. Drugs"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1111\/bjd.13443","article-title":"Long-term safety and efficacy of bimatoprost solution 0.03% application to the eyelid margin for the treatment of idiopathic and chemotherapy-induced eyelash hypotrichosis: A randomized controlled trial","volume":"172","author":"Glaser","year":"2015","journal-title":"Br. J. Dermatol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00266-014-0293-7","article-title":"Bimatoprost for eyelash growth in Japanese subjects: Two multicenter controlled studies","volume":"38","author":"Harii","year":"2014","journal-title":"Aesthetic Plast. Surg."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s10549-020-06063-w","article-title":"Scalp cooling in breast cancer patients treated with docetaxel-cyclophosphamide: Patient- and nurse-reported results","volume":"186","author":"Coolbrandt","year":"2021","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"7218","DOI":"10.3390\/curroncol29100569","article-title":"Prospective Study Investigating the Efficacy and Safety of a Scalp Cooling Device for the Prevention of Alopecia in Women Undergoing (Neo)Adjuvant Chemotherapy for Breast Cancer","volume":"29","author":"Carbognin","year":"2022","journal-title":"Curr. Oncol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1111\/tbj.13711","article-title":"Use of scalp cooling device to prevent alopecia for early breast cancer patients receiving chemotherapy: A prospective study","volume":"26","author":"Giarratano","year":"2020","journal-title":"Breast J."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s10549-020-05968-w","article-title":"Impact of chemotherapy regimen and sequence on the effectiveness of scalp cooling for alopecia prevention","volume":"185","year":"2021","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1091\/mbc.e14-04-0916","article-title":"How Taxol\/paclitaxel kills cancer cells","volume":"25","author":"Weaver","year":"2014","journal-title":"Mol. Biol. Cell"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00520-024-08393-7","article-title":"Retrospective evaluation of Penguin Cold Caps for chemotherapy-induced alopecia","volume":"32","author":"Weaver","year":"2024","journal-title":"Support. Care Cancer"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s13691-019-00380-8","article-title":"Hair regrowth using a properly fitted scalp cooling cap during adjuvant chemotherapy for breast cancer","volume":"8","author":"Fushimi","year":"2019","journal-title":"Int. Cancer Conf. J."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s10549-017-4185-9","article-title":"Scalp cooling with adjuvant\/neoadjuvant chemotherapy for breast cancer and the risk of scalp metastases: Systematic review and meta-analysis","volume":"163","author":"Rugo","year":"2017","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/j.jid.2016.02.805","article-title":"Cell Cycle Phase-Specific Drug Resistance as an Escape Mechanism of Melanoma Cells","volume":"136","author":"Beaumont","year":"2016","journal-title":"J. Investig. Dermatol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.4161\/cc.10.14.16819","article-title":"The power of chemotherapeutic engineering: Arresting cell cycle and suppressing senescence to protect from mitotic inhibitors","volume":"10","author":"Blagosklonny","year":"2011","journal-title":"Cell Cycle"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.4161\/cc.21127","article-title":"CDK4\/6 inhibition antagonizes the cytotoxic response to anthracycline therapy","volume":"11","author":"McClendon","year":"2012","journal-title":"Cell Cycle"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1016\/S1470-2045(12)70553-3","article-title":"Pathobiology of chemotherapy-induced hair loss","volume":"14","author":"Paus","year":"2013","journal-title":"Lancet Oncol."},{"key":"ref_74","first-page":"2168","article-title":"Cell cycle-mediated drug resistance: An emerging concept in cancer therapy","volume":"7","author":"Shah","year":"2001","journal-title":"Clin. Cancer Res."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2174\/1568009033481967","article-title":"Taxanes: Microtubule and centrosome targets, and cell cycle dependent mechanisms of action","volume":"3","author":"Abal","year":"2003","journal-title":"Curr. Cancer Drug Targets"},{"key":"ref_76","first-page":"1935","article-title":"Differential mitotic responses to microtubule-stabilizing and -destabilizing drugs","volume":"62","author":"Chen","year":"2002","journal-title":"Cancer Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1158\/1078-0432.CCR-21-4302","article-title":"A Phase Ib\/II Study of the CDK4\/6 Inhibitor Ribociclib in Combination with Docetaxel plus Prednisone in Metastatic Castration-Resistant Prostate Cancer","volume":"28","author":"Rao","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1158\/1535-7163.MCT-05-0130","article-title":"Docetaxel induces cell death through mitotic catastrophe in human breast cancer cells","volume":"4","author":"Morse","year":"2005","journal-title":"Mol. Cancer Ther."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Smith, E.R., Huang, M., Schlumbrecht, M.P., George, S.H.L., and Xu, X.X. (2022). Rationale for combination of paclitaxel and CDK4\/6 inhibitor in ovarian cancer therapy\u2014Non-mitotic mechanisms of paclitaxel. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.907520"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"229ra243","DOI":"10.1126\/scitranslmed.3007965","article-title":"Cytotoxicity of paclitaxel in breast cancer is due to chromosome missegregation on multipolar spindles","volume":"6","author":"Zasadil","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"ref_81","unstructured":"(2024, September 20). CDK4\/6 Inhibitors for Metastatic Breast Cancer. Available online: https:\/\/www.komen.org\/breast-cancer\/metastatic\/metastatic\/cdk4-6-inhibitors-for-metastatic-breast-cancer\/."},{"key":"ref_82","first-page":"145","article-title":"Keratinocyte growth factor is an important endogenous mediator of hair follicle growth, development, and differentiation. Normalization of the nu\/nu follicular differentiation defect and amelioration of chemotherapy-induced alopecia","volume":"147","author":"Danilenko","year":"1995","journal-title":"Am. J. Pathol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.7150\/jca.71263","article-title":"Low Intensity Ultrasound as an Antidote to Taxane\/Paclitaxel-induced Cytotoxicity","volume":"13","author":"Amaya","year":"2022","journal-title":"J. Cancer"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1016\/j.jid.2023.02.033","article-title":"Low-Intensity Ultrasound as a Potential Intervention Strategy to Protect Human Scalp Hair Follicles from Taxane-Induced Toxicity","volume":"143","author":"Cheret","year":"2023","journal-title":"J. Investig. Dermatol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jgr.2015.07.004","article-title":"Protective effect of Korean Red Ginseng against chemotherapeutic drug-induced premature catagen development assessed with human hair follicle organ culture model","volume":"40","author":"Keum","year":"2016","journal-title":"J. Ginseng Res."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jid.2020.05.118","article-title":"Inhibition of Shh Signaling through MAPK Activation Controls Chemotherapy-Induced Alopecia","volume":"141","author":"Haslam","year":"2021","journal-title":"J. Investig. Dermatol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1126\/science.2218498","article-title":"Protection from chemotherapy-induced alopecia in a rat model","volume":"249","author":"Hussein","year":"1990","journal-title":"Science"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00000441-199508000-00001","article-title":"Pretreatment with 1,25(OH)2D3 protects from Cytoxan-induced alopecia without protecting the leukemic cells from Cytoxan","volume":"310","author":"Jimenez","year":"1995","journal-title":"Am. J. Med. Sci."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"e00309","DOI":"10.1016\/j.heliyon.2017.e00309","article-title":"Wound healing protects against chemotherapy-induced alopecia in young rats via up-regulating interleukin-1beta-mediated signaling","volume":"3","author":"Stojadinovic","year":"2017","journal-title":"Heliyon"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.canep.2009.07.006","article-title":"The effect of active hexose correlated compound in modulating cytosine arabinoside-induced hair loss, and 6-mercaptopurine- and methotrexate-induced liver injury in rodents","volume":"33","author":"Sun","year":"2009","journal-title":"Cancer Epidemiol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1046\/j.1440-1827.2000.01021.x","article-title":"Time-specific occurrence of alopecia in neonatal C57BL mice treated with N-methyl-N-nitrosourea and the therapeutic efficacy of tacrolimus hydrate","volume":"50","author":"Yoshizawa","year":"2000","journal-title":"Pathol. Int."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Zhang, Y., and Jimenez, J.J. (2022). Mild oxidative stress protects against chemotherapy-induced hair loss. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.1078916"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1365-2230.2011.04239.x","article-title":"A novel rat model for chemotherapy-induced alopecia","volume":"37","author":"Wikramanayake","year":"2012","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/15569527.2023.2300790","article-title":"The efficacy of HDDPiW-jSB solution on docetaxel-induced alopecia of rats","volume":"43","author":"Demir","year":"2024","journal-title":"Cutan. Ocul. Toxicol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.0022-202X.2005.23787.x","article-title":"A guide to assessing damage response pathways of the hair follicle: Lessons from cyclophosphamide-induced alopecia in mice","volume":"125","author":"Hendrix","year":"2005","journal-title":"J. Investig. Dermatol."},{"key":"ref_96","first-page":"719","article-title":"Chemotherapy-induced alopecia in mice. Induction by cyclophosphamide, inhibition by cyclosporine A, and modulation by dexamethasone","volume":"144","author":"Paus","year":"1994","journal-title":"Am. J. Pathol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"6127","DOI":"10.1007\/s00520-021-06189-7","article-title":"Preventive effect of edaravone ointment on cyclophosphamide-chemotherapy induced alopecia","volume":"29","author":"Yoneda","year":"2021","journal-title":"Support. Care Cancer"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.0022-202x.2001.01377.x","article-title":"A comprehensive guide for the accurate classification of murine hair follicles in distinct hair cycle stages","volume":"117","author":"Handjiski","year":"2001","journal-title":"J. Investig. Dermatol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1001\/archderm.1987.01660250050016","article-title":"Hair growth in scalp grafts from patients with alopecia areata and alopecia universalis grafted onto nude mice","volume":"123","author":"Gilhar","year":"1987","journal-title":"Arch. Dermatol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1046\/j.1365-2133.1997.19382053.x","article-title":"A controlled study of the effects of RU58841, a non-steroidal antiandrogen, on human hair production by balding scalp grafts maintained on testosterone-conditioned nude mice","volume":"137","author":"Tetelin","year":"1997","journal-title":"Br. J. Dermatol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jaut.2018.04.001","article-title":"iNKT cells ameliorate human autoimmunity: Lessons from alopecia areata","volume":"91","author":"Ghraieb","year":"2018","journal-title":"J. Autoimmun."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1067\/mjd.2003.95","article-title":"Transplants from balding and hairy androgenetic alopecia scalp regrow hair comparably well on immunodeficient mice","volume":"48","author":"Krajcik","year":"2003","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1749-6632.1991.tb24425.x","article-title":"Reduced linear hair growth rates of vellus and of terminal hairs produced by human balding scalp grafted onto nude mice","volume":"642","author":"Dumortier","year":"1991","journal-title":"Ann. N. Y. Acad. Sci."}],"container-title":["Current Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1718-7729\/31\/9\/423\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:00:21Z","timestamp":1760112021000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1718-7729\/31\/9\/423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,23]]},"references-count":103,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["curroncol31090423"],"URL":"https:\/\/doi.org\/10.3390\/curroncol31090423","relation":{},"ISSN":["1718-7729"],"issn-type":[{"value":"1718-7729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,23]]}}}